Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Work In Process (2023 - 2024)

Historic Work In Process for Harmony Biosciences Holdings (HRMY) over the last 2 years, with Q4 2024 value amounting to $3.5 million.

  • Harmony Biosciences Holdings' Work In Process rose 7272.28% to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.5 million, marking a year-over-year increase of 7272.28%. This contributed to the annual value of $3.5 million for FY2024, which is 7272.28% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Work In Process of $3.5 million as of Q4 2024, which was up 7272.28% from $2.5 million recorded in Q3 2024.
  • Harmony Biosciences Holdings' 5-year Work In Process high stood at $3.5 million for Q4 2024, and its period low was $1.7 million during Q2 2024.